http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2008000422-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14
filingDate 2008-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fb352b1d14977a57ef48a05141fa379
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e11e968556decec6cf00903934a155d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b342171c0562400453f3cc524f59d48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75319cc58fe96388d3f84b8042e97bd
publicationDate 2009-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2008000422-A1
titleOfInvention The compound 4- [4- (2-adamantylcarbamoyl) -5-tert-butylpyrazol-1-yl] -benzoic acid; pharmaceutical composition; its use as an inhibitor of 11bhsd1, useful in the treatment of type 2 diabetes and obesity.
abstract Substituted pyrazole derived compounds; Preparation process; pharmaceutical composition; and use to produce an inhibitory effect of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 in diseases, such as, metabolic syndrome.
priorityDate 2007-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414135352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25006684

Total number of triples: 29.